Results 151 to 160 of about 9,108 (207)

Systemic loxoscelism with hemolysis and positive Coombs: diagnostic and physiopathological implications. [PDF]

Rev Inst Med Trop Sao Paulo
Costa JA, Rocha LR, Andrade Filho A, Haddad CMSLD, Almeida JS.   +4 more
europepmc   +1 more source

A proactive multidisciplinary approach to <i>Naja atra</i> envenomation reduces surgical burden and length of hospital stay. [PDF]

J Venom Anim Toxins Incl Trop Dis
Huang HP, Yeh TK, Huang PH, Lai KL, Lai CS, Liu PY, Mao YC.   +6 more
europepmc   +1 more source

Predictive value of admission blood glucose for early severity stratification in pediatric scorpion envenomation. [PDF]

J Venom Anim Toxins Incl Trop Dis
Dos Santos TF, Lages ATC, Andrade A, Saldanha J, da Silva GG, Chavez-Olortegui C, Rocha MODC.   +6 more
europepmc   +1 more source

Antivenomous serums

, 2008
Goyffon, M., /Chippaux, Jean-Philippe
openaire   +1 more source

A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa

Toxicon, 2003
Currently there is a crisis in the supply of antivenom for treatment of snake bite in sub-Saharan Africa. Commercial pressures have resulted in the reduction or even cessation of production of antivenom by European manufacturers while continued ...
David Warrell, Robert Harrison, Gavin D Laing   +2 more
exaly   +2 more sources

Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005
A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa.
José Maria Gutierrez, Gavin D Laing, Gustavo Rojas   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Availability of adder antivenom

Veterinary Record, 2014
WE read with interest the letter on the availability of adder antivenom by Alan Sim ( VR , June 7, 2014, vol 174, p 586) and share his concerns. Supply of adder antivenom for the treatment of animals is always an issue but has recently become more acute with the cessation of production of European Adder Antivenom …
Nicola, Bates, Nick, Edwards
openaire   +4 more sources

Venoms, antivenoms and immunotherapy

Toxicon, 1998
A century after the discovery of antivenom and despite real progress undertaken in its manufacture, its use remains largely empirical. Recent studies of pharmacokinetics of envenoming permitted improved understanding of immunotherapy. Improved purification of the antivenom by using immunoglobulin fragments has lead to increased tolerance and efficiency
/Chippaux, Jean-Philippe, Goyffon, M.
openaire   +2 more sources

Antivenom Therapy in the Americas

Drugs, 1999
Envenomations are an important cause of injury in the Americas. While supportive care alone may result in an acceptable outcome, antivenom offers a specific therapy that can significantly reduce the injury and symptoms of the envenomation. Antivenoms are hyperimmune sera collected from animals immunised with venom. The antibodies contained in the serum
K, Heard, G F, O'Malley, R C, Dart
openaire   +2 more sources